Search
Search Results
##search.searchResults.foundPlural##
-
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
4899PDF: 1848HTML: 2859Untitled: 243 -
-
Bordetella Bronchiseptica in the Immunosuppressed Population – A Case Series and Review.
2548PDF: 1347HTML: 1812CoverLetter: 196 -
-
FUNGAL INFECTIONS OF THE EAR IN IMMUNOCOMPROMISED HOST: A REVIEW
3814PDF: 1455HTML: 3856Letter to Editor: 204 -
HEPARIN-BINDING PROTEIN AS A DIAGNOSTIC AND PROGNOSTIC MARKER OF INFECTIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS Heparin-binding protein in adult patients
2965PDF: 1060HTML: 260Suppl. Files: 528 -
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
4539PDF: 1513HTML: 8530 -
ZYGOMYCOSIS IN IMMUNOCOMPROMISED NON-HAEMATOLOGICAL PATIENTS
2944PDF: 988HTML: 7489 -
Editorial : INTRODUCING MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES
3392PDF: 601HTML: 714 -
CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA
8193PDF: 4374HTML: 7544 -
A Case of Rupioid Syphilis Masquerading as Aggressive Cutaneous Lymphoma
2540PDF: 1062HTML: 5107Cover Letter: 180Figure 2: 179Figure 1: 186Figure 3: 212Figure 4: 182Figure Legend: 196Table 1: 204Table 2: 197Table 3: 194 -
EVALUATION OF USING EMPIRIC GLYCOPEPTIDES IN ACCORDANCE WITH THE IDSA GUIDELINE IN HEMATOLOGIC MALIGNANCY PATIENTS WITH FEBRILE NEUTROPENIA Empiric glycopeptide use in neutropenic fever
1579PDF: 1125HTML: 259 -
Brain abscesses caused by Nocardia paucivorans in a multiple myeloma patient treated with lenalidomide and dexamethasone: a case report and review of literature.
1747PDF: 1107HTML: 6557original file with images: 299 -
ASSESSMENT OF THE EFFICACY OF PROCALCITONIN, C-REACTIVE PROTEIN AND ALBUMIN LEVELS-GUIDED ANTIBIOTICS USE IN SEPSIS
995PDF: 588Html: 276Suppl. Files: 187 -
How we manage invasive fungal disease in acute myeloid leukemia patients with Glucose 6 Dehydrogenase deficiency
1873PDF: 934HTML: 1018Referring article: 771 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2450PDF: 1699HTML: 458 -
SIMPLE PERIPHERAL BLOOD SMEAR FINDINGS OF COVID-19 PATIENTS PROVIDE INFORMATION ABOUT THE SEVERITY OF THE DISEASE AND THE DURATION OF HOSPITAL STAY. Peripheral blood smear and COVID-19 severity.
3496PDF: 1212HTML: 496 -
PERIOPERATIVE MANAGEMENT OF SICKLE CELL DISEASE: A NARRATIVE REVIEW
9753PDF: 3304HTML: 1602







